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Efﬁcacy of radiofrequency (RF) catheter ablation in suppressing atrial ﬁbrillation (AF) 
was studied by analysis of heart rate variability (HRV) in 13 patients with atrial ﬂutter 
complicated with AF.  We treated these patients by RF ablation of the isthmus between 
the tricuspid valve annulus and the inferior vena cava to create a bidirectional conduc-
tion block.  To analyze the HRV, 24-h ambulatory electrocardiographic monitoring was 
performed 1 day before, 1 day after and 1 month after the ablation.  After the RF abla-
tion of the isthmus, 7 patients continued to experience AF attacks, while the remaining 
6 patients did not.  We divided them into 2 groups, attacked by AF (AF group) and not 
attacked by AF (non-AF group), and analyzed HRV parameters.  The results obtained 
were compared between the groups.  One month after the ablation, the non-AF group 
showed a signiﬁcantly higher average heart rate than the AF group.  The HRV param-
eters indicating cardiac vagal nervous activities, such as the root-mean-square of dif-
ferences, percentage of adjacent normal RR intervals and high frequency power, were 
signiﬁcantly lower in the non-AF group 1 month after.  Furthermore, the ratio of low 
frequency power to high frequency power, which is a measure for cardiac sympathetic 
nervous activity, was signiﬁcantly higher in the non-AF group 1 month after.  From these 
results, we postulate that the suppression of postoperative AF may involve vagal nerve 
suppression and sympathetic nerve activation. 
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Radiofrequency (RF) catheter ablation of the isth-
mus between the tricuspid valve annulus and the 
inferior vena cava (TVA-IVC isthmus) has become 
an effective procedure for radical treatment of 
common type atrial flutter (AFL).  However, late 
recurrence of atrial ﬁbrillation (AF) following suc-
cessful ablation still remains an important clinical 
problem.  Though RF ablation of AF has spread 
rapidly since Haissaguerre et al. (1998), pulmonary 
vein stenosis (Saad et al., 2003) and atrio-esopha-
geal ﬁstula (Pappone et al., 2004a) after ablation of 
AF were reported as severe complications.  Also, 
pulmonary vein ablation of AF may predispose to 
proarrhythmias such as left atrial macroreentrant 
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tachycardias (Pappone et al., 2004b).  It has been 
reported that RF ablation for common type AFL of 
the TVA-IVC isthmus is effective in reducing the 
incidence of AF attacks (Feld et al., 1992; Lesh et al., 
1994; Philippon et al., 1995; Saxon et al., 1996; Huang 
et al., 1998; Paydak et al., 1998; Tai et al., 1998; Na-
bar et al., 1999; Kumagai et al., 2000).  Huang et al. 
(1998) reported that, in patients who experienced 
conversion of AF to AFL during antiarrhythmic 
drug treatment, ablation for AFL and continuation 
of pharmacologic therapy were effective means of 
maintaining sinus rhythm.  As such, hybrid therapy 
is well-known and effective not only in patients 
experiencing a pharmacologic conversion of AF to 
AFL, but also in patients with both AF and AFL 
(Feld et al., 1992; Lesh et al., 1994; Philippon et al., 
1995; Saxon et al., 1996; Paydak et al., 1998; Tai et al., 
1998; Nabar et al., 1999; Kumagai et al., 2000).  We 
wanted to characterize patients in which ablation 
for AFL is also effective in suppression of con-
comitant AF.  In this regard, a number of reports 
have described the clinical features of such patients 
(Feld et al., 1992; Lesh et al., 1994; Philippon et al., 
1995; Saxon et al., 1996; Paydak et al., 1998; Tai et 
al., 1998; Nabar et al., 1999; Kumagai et al., 2000). 
However, there is no report to characterize auto-
nomic nervous function using heart rate variability 
(HRV) analysis in effective cases for suppression 
of concomitant AF after ablation for AFL.  In the 
present study, changes in autonomic nervous func-
tion before and after ablation in the postoperative 
AF patients group were compared with the non-AF 
group using HRV analysis.
Subjects and Methods
Informed consent was obtained from all patients 
prior to 24-h ambulatory electrocardiography 
(ECG) 1 day before ablation.
Patient population
A total of 13 patients (11 males and 2 females, age 
59.5 ± 9.7 years, duration of observation 6.5 ± 4 
months) having had both AF and AFL before abla-
tion, were selected by satisfying all the following 
criteria:  i) subjective attacks of paroxysmal tachy-
cardia (AF or AFL), ii) paroxysmal AF, iii) no use 
of autonomic drugs (β blockers, etc.), iv) no thyroid 
disease or valvular heart disease, v) the ablated 
site of the exact isthmus, excluding the posterior 
septum, and vi) no switchover of medication during 
the observation period. The observation period was 
from the day of ablation to September 11, 2004. 
 These patients were divided into 2 groups: 
7 patients (6 males and 1 female, age 58.3 ± 9.2 
years, duration of observation 5.9 ± 3.4 months) 
Table 1.  Patient characteristics
   Group  Patient Age (year)   Sex      Cardiovascular diagnosis Antiarrhythmic drug
AF group   Patient 1 66 Male PAFL, PAF   Pilsicainide, Digitalis
 Patient 2 54 Male PAFL, PAF   Cibenzoline
 Patient 3 78 Male  PAFL, PAF   None
 Patient 4 55 Female  PAFL, PAF, OMI Bepridil, Flecainide
 Patient 5 57 Male PAFL, PAF  Cibenzoline, Pilsicainide
 Patient 6 52 Male  PAFL, PAF  Cibenzoline
 Patient 7 48 Male PAFL, PAF   None
Non-AF group Patient 1 51 Male PAFL, PAF   None
 Patient 2  45  Male PAFL, PAF   Aprindine
 Patient 3 68  Male PAFL, PAF, OMI Pilsicainide, Digitalis
 Patient 4 65  Male PAFL, PAF Cibenzoline, Verapamil
 Patient 5 63   Female  PAFL, PAF  Aprindine, Digitalis
 Patient 6 74  Male PAFL, PAF  Pilsicainide
OMI, old myocardial infarction; PAF, paroxysmal atrial ﬁbrillation; PAFL, paroxysmal atrial ﬂutter. 
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with paroxysmal AF recorded with 12-lead ECGs 
on paroxysmal attacks during the observation pe-
riod after ablation (AF group) and 6 patients (5 
males and 1 female, age 61.0 ± 9.9 years, duration 
of observation 7.2 ± 5.6 months) without AF (non-
AF group) (Table 1). There was no signiﬁcant dif-
ference in sex, age, observation period or clinical 
features between the 2 groups. 
RF catheter ablation
After conﬁrming the involvement of the TVA-IVC 
isthmus in the tachycardia circuit during AFL, a 
bidirectional conduction block line was created 
in the TVA-IVC isthmus by ablation.  This abla-
tion was performed in the portion of the isthmus 
between the 6 and 7 o cʼlock directions in the left 
anterior oblique view, using a 6-mm deflectable 
large tip catheter.  Subsequently, cardiac pacing 
was performed from the low lateral right atrium 
and the coronary sinus, and the bidirectional block 
line in the TVA-IVC isthmus was conﬁrmed using 
the 20-electrode halo catheter method (Poty et al., 
1996) and the differential pacing method (Shah et 
al., 1999).  One of the 7 patients in the AF group 
and 1 of the 6 patients in the non-AF group had 
been suffering from spontaneous AFL before abla-
tion.  For the other patients, ablation was performed 
after inducing AFL by programmed stimulation.
Analysis of HRV
One day just before, 1 day just after and then 1 
month later after ablation, 24-h ambulatory ECG 
monitoring was performed using a 2-channel 
Holter monitor (Fukuda Denshi, Tokyo, Japan), 
and HRV was analyzed and evaluated using the 
ECG analytical software CHIRAM/MemCalc 
(GMS, Tokyo). The parameters determined were 
average heart rate (recorded by 24-h ambulatory 
ECG monitoring), time domain parameters and 
frequency domain parameters of HRV.  The time 
domain parameters were SD of 5-min mean RR 
intervals (SDNN), root-mean-square of differences 
of adjacent RR intervals (rMSSD) and percentage 
of adjacent normal RR intervals > 50 ms different 
(pNN50). The frequency domain parameters were 
low frequency power (LF) ranging from 0.04 to 0.15 
Hz, high frequency power (HF) ranging from 0.15 
to 0.40 Hz and the ratio of LF to HF (LF/HF). Of 
these parameters, SDNN, rMSSD, pNN50 and HF 
were reported to indicate cardiac vagal nervous ac-
tivities, and LF/HF to indicate cardiac sympathetic 
nervous activities (Task Force of the European So-
ciety of Cardiology and the North American Soci-
ety of Pacing and Electrophysiology, 1996).
Statistical Analysis
Data were presented as the mean ± SD.  Variables 
of average heart rate and HRV analysis were com-
pared using unpaired t-test.  A P value < 0.05 was 
considered statistically signiﬁcant.  
Results
RF catheter ablation
A bidirectional block was successfully created in 
all patients of both groups.  Statistical difference 
was examined for the number of RF application 
times (AF group versus non-AF group; 6.2 ± 4.3 
times versus 5.6 ± 4.0 times, not significant) and 
RF cumulative energy (AF group versus non-AF 
group; 21,962 ± 3,160 W•s versus 19,330 ± 2,966 
W•s, not signiﬁcant).  There was no patient expe-
riencing recurrent AFL during the observation pe-
riod (Table 2). 
Table 2.  Results of RF catheter ablation
 AF group   Non-AF group
 [n = 7] [n = 6]
Bidirectional block           7/7           6/6
RF application*        6.2 ± 4.3       5.6 ± 4.0
RF cumulative energy† 21,962 ± 3,160 19,330 ± 2,966
AFL recurrence            0/7            0/6
 Values are mean ± SD.   
 AF, atrial ﬁbrillation; AFL, atrial ﬂutter; RF, radiofre-
quency.
* (times)
† (W•s)
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Fig. 1.  The mean heart rate for the AF group and the non-AF group, just before, just after and 1 month after abla-
tion.  The non-AF group shows a signiﬁcantly higher value 1 month after ablation.  NS, not signiﬁcant.
24-h Ambulatory ECG monitoring and av-
erage heart rate
Compared between the AF and the non-AF groups, 
the average heart rates just before ablation and just 
after ablation, 85.2 ± 39.4 versus 67.8 ± 16.7 beats/min 
and 67.3 ± 13.1 versus 71.8 ± 12.3 beats/min, respec-
tively, showed no significant difference.  The differ-
ence in average heart rate 1 month after ablation was 
signiﬁcantly (P < 0.05) higher for the non-AF group, 
61.3 ± 10.2 versus 74.8 ± 11.1 beats/min (Fig. 1). 
Time domain parameters of HRV
The SDNNs just before, just after and 1 month after 
ablation compared between the AF and the non-AF 
groups were not signiﬁcantly different, respectively 
(Fig. 2).  
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Fig. 2.  The SD of RR intervals (SDNN) for the AF group and the non-AF group:  196.9 ± 78.3 versus 112.1 ± 59.0 
ms just before ablation; 123.6 ± 48.8 versus 99.4 ± 32.6 ms just after ablation; and 174.9 ± 47.7 versus 143.6 ± 58.5 
ms 1 month after ablation.  Differences between groups are not signiﬁcant (NS).
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 The rMSSDs compared between the 2 groups 
just before ablation, 60.9 ± 25.6 versus 23.2 ± 9.6 
ms, were signiﬁcantly (P < 0.05) lower for the non-
AF group, as well as levels 1 month after ablation, 
59.1 ± 23.7 versus 18.0 ± 5.7 ms (P < 0.05).  The 
difference in levels just after ablation, 44.4 ± 23.7 
versus 24.7 ± 18.2 ms, was not signiﬁcant (Fig. 3). 
 The pNN50s just before ablation and 1 month 
after ablation were 16.5 ± 11.9 versus 2.7 ± 3.0% 
and 20.0 ± 12.1 versus 1.4 ± 1.3%, respectively, 
showing signiﬁcantly (P < 0.05 both) lower levels 
for the non-AF group.  The levels just after abla-
tion, 10.3 ± 8.4 versus 3.8 ± 6.7%, were not signiﬁ-
cantly different (Fig. 4).
Fig. 3.  The root-mean-square of differences (rMSSD) for the AF group and the non-AF group, just before, just after 
and 1 month after ablation.  The non-AF group shows signiﬁcantly lower values just before and 1 month after abla-
tion.  NS, not signiﬁcant.   
Fig. 4.  The percentage of adjacent normal RR intervals (pNN50) for the AF group and the non-AF group, just 
before, just after and 1 month after ablation.  The non-AF group shows signiﬁcantly lower values just before and 1 
month after ablation.  NS, not signiﬁcant.  
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Fig. 6.  The ratio of low frequency power/high frequency power (LF/HF) for the AF group and the non-AF group, 
just before, just after and 1 month after ablation.  The non-AF group shows a signiﬁcantly higher value 1 month after 
ablation.  NS, not signiﬁcant.
Frequency domain parameters of HRV
The HF levels compared between the groups were 
462.3 ± 386.8 versus 115.8 ± 109.7 ms2 just before 
ablation, 221.1 ± 150.7 versus 108.4 ± 137 ms2 
just after ablation and 460.4 ± 358.7 versus 62.2 ± 
55.6 ms2 1 month after ablation.  The difference 1 
month after ablation was signiﬁcantly lower for the 
non-AF group (Fig. 5).
 The compared LF/HF levels were 1.8 ± 0.8 
versus 1.8 ± 1.1 just before ablation and 1.6 ± 0.7 
versus 2.1 ± 0.7 just after ablation, showing no sig-
niﬁcant differences between the groups.  The levels 
1 month after ablation, 1.7 ± 0.7 versus 2.9 ± 0.9, 
were signiﬁcantly (P < 0.05) higher for the non-AF 
group (Fig. 6).
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Fig. 5.  The high frequency power (HF) for the AF group and the non-AF group, just before, just after and 1 month 
after ablation.  The non-AF group shows a signiﬁcantly lower value 1 month after ablation.  NS, not signiﬁcant.
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Discussion
It has been reported that ablation for common type 
AFL, which circles between the tricuspid valve an-
nulus and the inferior vena cava, is effective in re-
ducing the incidence of AF attacks, and the percent 
incidence of AF after ablation of the TVA-IVC 
isthmus is reportedly variable, from 8% to 86% 
(Feld et al., 1992; Lesh et al., 1994; Philippon et al., 
1995; Saxon et al., 1996; Paydak et al., 1998; Tai et 
al., 1998; Nabar et al., 1999; Kumagai et al., 2000). 
Regarding the identity of cases in which ablation 
of the TVA-IVC isthmus is effective in suppressing 
AF, Philippon et al. (1995) reported that the risk of 
postoperative AF was especially high for patients 
in whom sustained AF remained inducible after ab-
lation of AFL, while Paydak et al. (1998) reported 
the same ﬁnding in the presence of both a past his-
tory of AF and a left ventricular ejection fraction 
of 50% or less.  Nabor et al. (1999) reported low 
AF suppressing effects in patients frequently expe-
riencing AF episodes before ablation.  They also 
reported that there were 3 mechanisms for the co-
existence of AF and AFL:  i) a difference between 
the 2 atria, the right atrium showing AFL and the 
left atrium showing AF; ii) AFL in the right atrium 
becoming unstable or irregular and hence leading 
to AF; and iii) a time lag between AFL and AF. 
They concluded that in cases i) and ii) ablation for 
AFL was also effective against AF (Nabar et al., 
1999).
 Regarding the distribution of vagal nervous ﬁ-
bers to the cardiac sinoatrial node and atrioventric-
ular node, relatively extensive investigations have 
been conducted.  Randall and Ardell (1990) point-
ed out the importance of the atrial septum as the 
anatomical route for this distribution as the course 
of vagal nervous postganglionic fibers from the 
right pulmonary venous adipose tissue to the sino-
atrial node passing between the 2 atria.  Since the 
early days of the spread of ablation as a therapeutic 
technique, it has been known that some patients ex-
perience sinus tachycardia mainly after ablation of 
the fast pathway in atrioventricular nodal reentrant 
tachycardia (AVNRT), and possible disturbance 
of autonomic nervous function due to ablation has 
been postulated (Ehlert et al., 1992).  Kocovic et 
al. (1993) investigated autonomic nervous func-
tion from the viewpoint of HRV after ablation for 
supraventricular tachycardia, and reported that the 
HF of HRV decreased only in AVNRT and septal 
ablation of the posterior septum accessory pathway. 
With regard to ablation for AFL, Li et al. (2002) 
reported that ordinary ablation of the TVA-IVC 
isthmus did not affect autonomic nervous function 
in terms of HRV.  Kawamura et al. (2002) investi-
gated differences related to AFL ablation sites, and 
reported that the HF of HRV decreased only in the 
site of the posterior septum, rather than in the ordi-
nary TVA-IVC isthmus.
 In the present study, we investigated HRV just 
before ablation, just after ablation and 1 month af-
ter ablation in order to characterize cases in which 
ablation for AFL was also effective in suppressing 
AF.  As a result, signiﬁcantly lower values of rMS-
SD and pNN50 were obtained from the non-AF 
group just before ablation.  However, 1 month after 
ablation, a higher value of average heart rate, lower 
values of rMSSD and pNN50, a lower value of HF 
and a higher value of LF/HF were obtained for the 
non-AF group than for the AF group.  These results 
demonstrate suppression of vagal nervous function 
and accentuation of sympathetic nervous function 
in the non-AF group 1 month after ablation.  These 
effects were not attributable to ablation because the 
cases in which RF application was delivered to the 
atrial septum were excluded from the analysis to 
avoid the possible inﬂuence of ablation on the au-
tonomic nervous system.  As for why a signiﬁcant 
difference became clear 1 month after ablation, we 
postulated i) changes in autonomic nervous func-
tion due to the disappearance of AFL and ii) a 
latent abnormality of autonomic nervous function 
becoming symptomatic.  Although the mechanism 
remains unclear, these results suggested that analy-
sis of HRV 1 month after ablation might enable 
selection of cases in which ablation of the TVA-
IVC isthmus is also effective in the suppression the 
recurrence of AF.  For appropriate follow-up, the 
case to require anticoagulant and antiarrthythmic 
drugs should be clariﬁed.  And we suppose that for 
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patients with postoperative recurrent AF, drugs that 
suppress vagal nervous function and accentuate 
sympathetic nervous function might be more effec-
tive than other drugs.
 In the present study, HRV was analyzed to 
evaluate autonomic nervous function in AFL pa-
tients with paroxysmal AF, whereas other means of 
evaluation for cardiac autonomic nervous function 
such as baroreceptor reﬂex and 123I-metaiodoben-
zylguanidine scintigraphy were not used.  Because 
of the many requirements for studying a popula-
tion, the sample size of this study was not enough 
to ensure data reliability.  Additionally, the study 
was conducted in a relatively short period, from 
just before and just after ablation to 1 month after 
ablation.  Further investigation ranging over an ex-
tended period will be necessary.
Conclusion
To characterize the autonomic nervous function 
profiles in cases in which ablation for AFL is ef-
fective in suppressing concomitant AF, HRV was 
analyzed in patients with both AF and AFL.  In 
the group with suppressed AF after ablation, a 
significantly higher value of average heart rate, 
significantly lower values of rMSSD, pNN50 and 
HF, and a signiﬁcantly higher value of LF/HF were 
obtained 1 month after ablation, showing charac-
teristic changes in autonomic nervous function.
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patients with postoperative recurrent AF, drugs that 
suppress vagal nervous function and accentuate 
sympathetic nervous function might be more effec-
tive than other drugs.
 In the present study, HRV was analyzed to 
evaluate autonomic nervous function in AFL pa-
tients with paroxysmal AF, whereas other means of 
evaluation for cardiac autonomic nervous function 
such as baroreceptor reﬂex and 123I-metaiodoben-
zylguanidine scintigraphy were not used.  Because 
of the many requirements for studying a popula-
tion, the sample size of this study was not enough 
to ensure data reliability.  Additionally, the study 
was conducted in a relatively short period, from 
just before and just after ablation to 1 month after 
ablation.  Further investigation ranging over an ex-
tended period will be necessary.
Conclusion
To characterize the autonomic nervous function 
profiles in cases in which ablation for AFL is ef-
fective in suppressing concomitant AF, HRV was 
analyzed in patients with both AF and AFL.  In 
the group with suppressed AF after ablation, a 
significantly higher value of average heart rate, 
significantly lower values of rMSSD, pNN50 and 
HF, and a signiﬁcantly higher value of LF/HF were 
obtained 1 month after ablation, showing charac-
teristic changes in autonomic nervous function.
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